Visco Vision Inc.
Visco Vision Inc. manufactures and sells silicone hydrogel contact lenses in Asia, Europe, and the Americas. The company offers spherical, multifocal, toric, cosmetic, and color lenses. It also provides medical and lease management services. The company was incorporated in 1998 and is based in Taoyuan City, Taiwan.
Visco Vision Inc. (6782) - Net Assets
Latest net assets as of September 2025: NT$3.98 Billion TWD
Based on the latest financial reports, Visco Vision Inc. (6782) has net assets worth NT$3.98 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$5.82 Billion) and total liabilities (NT$1.84 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$3.98 Billion |
| % of Total Assets | 68.44% |
| Annual Growth Rate | 34.32% |
| 5-Year Change | 344.6% |
| 10-Year Change | N/A |
| Growth Volatility | 68.04 |
Visco Vision Inc. - Net Assets Trend (2019–2024)
This chart illustrates how Visco Vision Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Visco Vision Inc. (2019–2024)
The table below shows the annual net assets of Visco Vision Inc. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$3.72 Billion | +24.61% |
| 2023-12-31 | NT$2.98 Billion | -4.06% |
| 2022-12-31 | NT$3.11 Billion | +179.23% |
| 2021-12-31 | NT$1.11 Billion | +33.19% |
| 2020-12-31 | NT$835.89 Million | -1.61% |
| 2019-12-31 | NT$849.55 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Visco Vision Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 227.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$1.24 Billion | 33.51% |
| Common Stock | NT$630.00 Million | 17.04% |
| Other Components | NT$1.83 Billion | 49.45% |
| Total Equity | NT$3.70 Billion | 100.00% |
Visco Vision Inc. Competitors by Market Cap
The table below lists competitors of Visco Vision Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orezone Gold Corp
OTCQX:ORZCF
|
$217.82 Million |
|
Xiamen Jiarong Technology Corp. Ltd.
SHE:301148
|
$217.86 Million |
|
Tianjin Ruixin Technology Co Ltd
SHE:300828
|
$217.91 Million |
|
Avex Inc.
PINK:AVEXF
|
$217.95 Million |
|
Guangdong Xiongsu Technology Group Co Ltd
SHE:300599
|
$217.64 Million |
|
V-Mart Retail Limited
NSE:VMART
|
$217.60 Million |
|
Taiwan Mask Corp
TW:2338
|
$217.60 Million |
|
Priority Technology Holdings Inc Unit
PINK:PRTHU
|
$217.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Visco Vision Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,964,940,000 to 3,697,047,000, a change of 732,107,000 (24.7%).
- Net income of 636,471,000 contributed positively to equity growth.
- Dividend payments of 151,200,000 reduced retained earnings.
- Other comprehensive income increased equity by 194,181,000.
- Other factors increased equity by 52,655,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$636.47 Million | +17.22% |
| Dividends Paid | NT$151.20 Million | -4.09% |
| Other Comprehensive Income | NT$194.18 Million | +5.25% |
| Other Changes | NT$52.66 Million | +1.42% |
| Total Change | NT$- | 24.69% |
Book Value vs Market Value Analysis
This analysis compares Visco Vision Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.26x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.28x to 3.26x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$15.51 | NT$190.50 | x |
| 2020-12-31 | NT$15.10 | NT$190.50 | x |
| 2021-12-31 | NT$20.29 | NT$190.50 | x |
| 2022-12-31 | NT$55.28 | NT$190.50 | x |
| 2023-12-31 | NT$46.99 | NT$190.50 | x |
| 2024-12-31 | NT$58.47 | NT$190.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Visco Vision Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 17.33%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 1.43x
- Recent ROE (17.22%) is below the historical average (23.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 37.18% | 21.46% | 0.81x | 2.14x | NT$230.94 Million |
| 2020 | 15.32% | 8.39% | 0.69x | 2.66x | NT$44.48 Million |
| 2021 | 39.85% | 22.58% | 0.63x | 2.81x | NT$332.30 Million |
| 2022 | 20.02% | 22.23% | 0.52x | 1.72x | NT$309.01 Million |
| 2023 | 10.17% | 12.58% | 0.51x | 1.59x | NT$5.12 Million |
| 2024 | 17.22% | 17.33% | 0.69x | 1.43x | NT$266.77 Million |
Industry Comparison
This section compares Visco Vision Inc.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,796,147,300
- Average return on equity (ROE) among peers: 10.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Visco Vision Inc. (6782) | NT$3.98 Billion | 37.18% | 0.46x | $217.82 Million |
| St.Shine Optical Co Ltd (1565) | $5.39 Billion | 29.48% | 0.60x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.26 Billion | 10.49% | 0.61x | $128.74 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $22.68 Million |